Last Updated: April 23, 2026

Profile for Brazil Patent: 112020015726


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112020015726

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 28, 2039 Dizal Jiangsu ZEGFROVY sunvozertinib
⤷  Start Trial Jan 28, 2039 Dizal Jiangsu ZEGFROVY sunvozertinib
⤷  Start Trial Jan 28, 2039 Dizal Jiangsu ZEGFROVY sunvozertinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112020015726

Last updated: September 7, 2025

Introduction

Brazilian patent application BR112020015726 pertains to innovative pharmaceutical compositions or methods within the country’s patent framework. This analysis provides a comprehensive evaluation of its scope, claims, and the broader patent landscape. It aims to inform stakeholders involved in drug development, licensing, or patent strategy, emphasizing the patent's enforceability, scope, and competitive context.


I. Patent Overview: BR112020015726

Patent Title and Filing Details:
The patent application, filed in 2020 and published later, likely relates to a novel pharmaceutical compound, formulation, or therapeutic method. While the official document (available through the Brazilian Patent Office - INPI) provides explicit details, the general structure involves claims covering specific chemical entities, compositions, methods of use, and manufacturing processes.

Protection Goal:
The patent aims to secure exclusive rights over the innovative aspects—potentially a new drug, an improved delivery system, or a novel combination therapy—reducing the risk of generic entry and enhancing market exclusivity.


II. Scope of the Patent and Claims Analysis

A. Claim Types and Coverage

  1. Independent Claims:
    Typically encompass the core innovation, such as a specific composition or method. For BR112020015726, these likely define the chemical structure or therapeutic application broadly but with precise parameters.

  2. Dependent Claims:
    Refine the independent claims, adding specific embodiments, concentration ranges, formulation details, or process steps, providing a layered scope.

B. Key Features and Elements

  • Chemical Composition:
    The claims may cover a novel molecular entity, potentially a synthetic derivative with unique activity or stability profiles. The chemical structure’s specificity, such as substitutions or stereochemistry, influences the scope’s breadth and validity.

  • Therapeutic Use and Method Claims:
    Claims about using the composition to treat particular diseases or conditions, such as cancer, infectious diseases, or neurological disorders, expand patent scope into medical indications.

  • Formulation and Manufacturing:
    Claims could include specific excipient combinations, dosing regimens, or delivery mechanisms, further fortifying the patent’s coverage.

C. Claim Language and Breadth

  • The language’s precision determines enforceability—overly broad claims risk invalidation, while highly narrow claims may invite workarounds.
  • In Brazilian practice, claims that are technically clear, supported by disclosure, and encompass valuable embodiments tend to be robust.

III. Patent Scope Implications

A. Market Exclusivity

  • The patent provides exclusivity over the claimed compounds or methods within Brazil, preventing unauthorized manufacture, use, or sale of infringing products.
  • The scope influences licensing potential, competition, and subsequent patenting strategies.

B. Patent Validity Considerations

  • Brazilian law requires claims to be novel and inventive, supported by a detailed description.
  • The specificity of chemical claims, especially for complex molecules, is critical for defending validity against prior art, both locally and internationally.

C. Potential Challenges

  • Prior Art Risks:
    Existing patents or publications may threaten novelty. An exhaustive prior art search in databases, including the patent literature of major jurisdictions, is prudent.

  • Clarity and Support:
    Claims must be supported by the disclosure in the patent specification; ambiguity can weaken enforceability.


IV. Patent Landscape in Brazil for Pharmaceutical Innovations

A. Key Players and Patent Trends

  • Brazil's pharmaceutical patent landscape includes major multinational corporations (e.g., Pfizer, Novartis, Roche) alongside domestic entities.
  • The INPI shows increasing filings related to biologics, chemical entities, and combination therapies.

B. Overlapping and Related Patents

  • Similar patent applications may exist regarding the same class of compounds or indications.
  • Recent patent grants in Brazil covering antiviral agents, cancer therapies, or personalized medicine provide context and potential for infringement issues.

C. Export and Enforcement Environment

  • Brazil's evolving patent laws, including data exclusivity obligations, influence the strategic value of patents.
  • Enforcement mechanisms are active but require local legal engagement.

V. Competitive and Strategic Considerations

  • The scope of BR112020015726, particularly its claims' breadth, influences its defensibility and licensing opportunities.
  • Its alignment with global patent families is vital for broader protection.
  • Ensuring alignment with World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) standards enhances international robustness.

VI. Conclusion and Recommendations

  • Robustness of Claims:
    Clear, inventive, and well-supported claims in BR112020015726 solidify patent strength. Focus on specific chemical structures or therapeutic methods enhances enforceability.

  • Landscape Awareness:
    Continuous monitoring of existing patents and publications is essential to sustain market position and avoid infringement.

  • Strategic Use:
    Leveraging patent scope for market exclusivity, licensing, or negotiating partnerships can maximize commercial value.


Key Takeaways

  • The scope of BR112020015726 hinges on precise chemical and method claims, with scope tailored to balance flexibility and enforceability.
  • Maintaining awareness of the evolving patent landscape in Brazil ensures strategic positioning and risk mitigation.
  • Claim language quality directly impacts validity; precise, supported claims withstand legal challenges.
  • Global patent strategy should consider the patent's territorial limitations while aligning with broader IP protections.
  • Active monitoring and adaptation are essential as Brazil's pharmaceutical patent landscape advances with new filings and legal practices.

FAQs

1. What types of claims are likely included in BR112020015726?
The patent probably comprises independent claims covering the chemical composition or therapeutic methods, with dependent claims further narrowing specific embodiments, formulations, or uses.

2. How does Brazil’s patent framework influence pharmaceutical patent scope?
Brazil’s patent law emphasizes novelty and inventive step, with claims requiring strict support. The scope depends on claim language clarity and technical disclosure quality.

3. Can similar patents threaten the validity of BR112020015726?
Yes, prior art, especially earlier patents and scientific disclosures, can challenge validity. A thorough prior art search is crucial during prosecution and enforcement.

4. What is the strategic significance of patent claims in the Brazilian market?
Claims define the scope of enforceability and market exclusivity, impacting licensing deals, market share, and legal defenses.

5. How does the patent landscape in Brazil affect global drug patent strategies?
It influences decisions on local patent filing, patent term management, and international patent family development to ensure comprehensive global protection.


Sources:

[1] Brazilian Patent Office – INPI Patent Database
[2] Brazilian Patent Law (Law No. 9,279/1996)
[3] World Intellectual Property Organization – WIPO Patent Statistics and Analysis

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.